Vir Biotechnology (VIR) Leases (2020 - 2025)
Historic Leases for Vir Biotechnology (VIR) over the last 6 years, with Q3 2025 value amounting to $63.6 million.
- Vir Biotechnology's Leases rose 456.74% to $63.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.6 million, marking a year-over-year increase of 456.74%. This contributed to the annual value of $59.7 million for FY2024, which is 1615.86% down from last year.
- Per Vir Biotechnology's latest filing, its Leases stood at $63.6 million for Q3 2025, which was up 456.74% from $64.9 million recorded in Q2 2025.
- Over the past 5 years, Vir Biotechnology's Leases peaked at $88.3 million during Q1 2022, and registered a low of $57.6 million during Q3 2021.
- Moreover, its 5-year median value for Leases was $70.3 million (2024), whereas its average is $70.9 million.
- As far as peak fluctuations go, Vir Biotechnology's Leases skyrocketed by 28996.07% in 2021, and later plummeted by 1690.55% in 2024.
- Vir Biotechnology's Leases (Quarter) stood at $87.2 million in 2021, then dropped by 5.35% to $82.6 million in 2022, then dropped by 13.78% to $71.2 million in 2023, then decreased by 16.16% to $59.7 million in 2024, then grew by 6.49% to $63.6 million in 2025.
- Its Leases was $63.6 million in Q3 2025, compared to $64.9 million in Q2 2025 and $58.6 million in Q1 2025.